The long-term marriage between autoimmunity and internal medicine: A homage to manuel carlos dias

Clinical Reviews in Allergy and Immunology

Volumn 43, Issue 3, 2012, Pages 207-210

  Selmi, Carlo ^a,b   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Autoimmunologist; Geoepidemiology; Immune tolerance

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACADEMIC ACHIEVEMENT; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOIMMUNOLOGIST; HUMAN; INTERNAL MEDICINE; INTERNIST; MEDICAL LITERATURE; PHYSICIAN; HISTORY; IMMUNOLOGY; PORTUGAL; METHODOLOGY; REVIEW;

ALLERGY AND IMMUNOLOGY; AUTOIMMUNITY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTERNAL MEDICINE; PORTUGAL; AUTOIMMUNE DISEASES;

MLCS; MLOWN;

EID: 84871640897     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-012-8333-z     Document Type: Article

References (68)

1. Anaya JM, Shoenfeld Y, Cervera R (2012) Facts and challenges for the autoimmunologist. Lessons from the second Colombian autoimmune symposium. Autoimmun Rev 11:249-251
2. Matthias T, Shoenfeld Y (2010) Challenges for the autoimmunologist. Clin Rev Allergy Immunol 38:75-76
3. Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31:325-330
4. Amur S, Parekh A, Mummaneni P (2012) Sex differences and genomics in autoimmune diseases. J Autoimmun 38: J254-J265
5. Dillon SP, Kurien BT, Li S, Bruner GR, Kaufman KM, Harley JB, Gaffney PM, Wallace DJ, Weisman MH, Scofield RH (2012) Sex chromosome aneuploidies among men with systemic lupus erythematosus. J Autoimmun 38:J129-J134
6. Geurs TL, Hill EB, Lippold DM, French AR (2012) Sex differences in murine susceptibility to systemic viral infections. J Autoimmun 38: J245-J253
7. Peeva E (2011) Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors. Clin Rev Allergy Immunol 40:1-7
8. Behrens M, Trejo T, Luthra H, Griffiths M, David CS, Taneja V (2010) Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J Autoimmun 35:1-9
9. Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34:J314-J321
10. Invernizzi P (2010) Geoepidemiology of autoimmune liver diseases. J Autoimmun 34:J300-J306
11. Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34:J168-J177
12. Zeki AA, Schivo M, Chan AL, Hardin KA, Kenyon NJ, Albertson TE, Rosenquist GL, Louie S (2010) Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 34:J327-J338
13. Ballestar E (2010) Epigenetics lessons from twins: prospects for autoimmune disease. Clin Rev Allergy Immunol 39:30-41
14. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y (2010) Epigenetics and autoimmunity. J Autoimmun 34:J207-J219
15. Grolleau-Julius A, Ray D, Yung RL (2010) The role of epigenetics in aging and autoimmunity. Clin Rev Allergy Immunol 39:42-50
16. Maciejewska-Rodrigues H, Karouzakis E, Strietholt S, Hemmatazad H, Neidhart M, Ospelt C, Gay RE, Michel BA, Pap T, Gay S et al (2010) Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression. J Autoimmun 35:15-22
17. Renaudineau Y (2010) The revolution of epigenetics in the field of autoimmunity. Clin Rev Allergy Immunol 39:1-2
18. Renaudineau Y, Garaud S, Le Dantec C, Alonso-Ramirez R, Daridon C, Youinou P (2010) Autoreactive B cells and epigenetics. Clin Rev Allergy Immunol 39:85-94
19. Trenkmann M, Brock M, Ospelt C, Gay S (2010) Epigenetics in rheumatoid arthritis. Clin Rev Allergy Immunol 39:10-19
20. Zhao M, Sun Y, Gao F, Wu X, Tang J, Yin H, Luo Y, Richardson B, Lu Q (2010) Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J Autoimmun 35:58-69
21. Ospelt C, Reedquist KA, Gay S, Tak PP (2011) Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis? Autoimmun Rev 10:519-524
22. Moura RA, Graca L, Fonseca JE (2012) To B or not to B the conductor of rheumatoid arthritis orchestra. Clin Rev Allergy Immunol, in press
23. Herold KC, Pescovitz MD, McGee P, Krause-Steinrauf H, Spain LM, Bourcier K, Asare A, Liu Z, Lachin JM, Dosch HM (2011) Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes. J Immunol 187:1998-2005
24. Miserocchi E, Pontikaki I, Modorati G, Gattinara M, Meroni PL, Gerloni V (2011) Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases. Autoimmun Rev 11:35-39
25. Brandao M, Damasio J, Marinho A, da Silva AM, Vasconcelos J, Neves E, Almeida I, Farinha F, Vasconcelos C (2012) Systemic lupus erythematosus, progressive multifocal leukoencephalopathy, and T-CD4+ lymphopenia. Clin Rev Allergy Immunol. doi:10.1007/s12016-012-8327-x
26. Kawata K, Kobayashi Y, Gershwin ME, Bowlus CL (2012) The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis. Clin Rev Allergy Immunol. doi:10.1007/s12016- 012-8324-0
27. Haylock-Jacobs S, Comerford I, Bunting M, Kara E, Townley S, Klingler-Hoffmann M, Vanhaesebroeck B, Puri KD, McColl SR (2011) PI3Kdelta drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector Tcell apoptosis and promoting Th17 differentiation. J Autoimmun 36:278-287
28. Varin MM, Guerrier T, Devauchelle-Pensec V, Jamin C, Youinou P, Pers JO (2012) In Sjogren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev 11:252-258
29. Wang YH, Yan Y, Rice JS, Volpe BT, Diamond B (2011) Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism. J Autoimmun 37:18-27
30. Tanaka H, Leung PS, Kenny TP, Gershwin ME, Bowlus CL (2012) Immunological orchestration of liver fibrosis. Clin Rev Allergy Immunol. doi:10.1007/s12016- 012-8323-1
31. Chizzolini C, Brembilla NC, Montanari E, Truchetet ME (2011) Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 10:276-281
32. Wei J, Bhattacharyya S, Tourtellotte WG, Varga J (2011) Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmun Rev 10:267-275
33. Tervaert JWC, Damoiseaux J (2012) Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for the diagnosis, classification, and follow-up? Clin Rev Allergy Immunol. doi:10.1007/s12016-012- 8320-4
34. Hu N, Westra J, Kallenberg CG (2011) Dysregulated neutrophil-endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-Associated vasculitides: implications for pathogenesis and disease intervention. Autoimmun Rev 10:536-543
35. Yazici H, Ugurlu S, Seyahi E (2012) Behcet's syndrome: is it one condition? Clin Rev Allergy Immunol. doi:10.1007/s12016-012-8319-x
36. Martinez-Zamora MA, Cervera R, Balasch J (2012) Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease. Clin Rev Allergy Immunol. doi:10.1007/s12016-012-8316-0
37. Font C, Vidal L, Espinosa G, Tassies D, Monteagudo J, Farrus B, Visa L, Cervera R, Gascon P, Reverter JC (2011) Solid cancer, antiphospholipid antibodies, and venous thromboembolism. Autoimmun Rev 10:222-227
38. Andreoli L, Fredi M, Nalli C, Reggia R, Lojacono A, Motta M, Tincani A (2012) Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. J Autoimmun 38: J197-J208
39. Blank M, Baraam L, Eisenstein M, Fridkin M, Dardik R, Heldman Y, Katchalski-Katzir E, Shoenfeld Y (2011) Beta2-glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3beta expression and reduces experimental-Antiphospholipid-syndrome. J Autoimmun 37:8-17
40. Anaya JM, Castiblanco J, Rojas-Villarraga A, Pineda-Tamayo R, Levy RA, Gomez-Puerta J, Dias C, Mantilla RD, Gallo JE, Cervera R et al (2012) The multiple autoimmune syndromes. A clue for the autoimmune tautology. Clin Rev Allergy Immunol. doi:10.1007/s12016-012-8317-z
41. Schioppo T, Artusi C, Ciavarella T, Ingegnoli F, Murgo A, Zeni S, Chighizola C, Meroni PL (2012) N-TproBNP as biomarker in systemic sclerosis. Clin Rev Allergy Immunol. doi:10.1007/s12016-012-8312-4
42. Bussone G, Mouthon L (2011) Interstitial lung disease in systemic sclerosis. Autoimmun Rev 10:248-255
43. Galluccio F, Matucci-Cerinic M (2011) Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis. Autoimmun Rev 10:241-243
44. Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R (2011) Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 10:590-594
45. Albers JM, Kuper HH, van Riel PL, Prevoo ML, van't Hof MA, van Gestel AM, Severens JL (1999) Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology (Oxford) 38:423-430 (Pubitemid 29507126)
46. March L, Lapsley H (2001) What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis? Best Pract Res Clin Rheumatol 15:171-185 (Pubitemid 32396435)
47. Phan TG, Ng WW, Bird D, Smithers K, Wong V, Gallagher K, Williams A, Adelstein S (2001) High-quality, cost-effective strategy for detection of autoantibodies to extractable nuclear antigens. Clin Diagn Lab Immunol 8:471-474 (Pubitemid 32428865)
48. Boonen A, Severens JL (2002) Ankylosing spondylitis: what is the cost to society, and can it be reduced? Best Pract Res Clin Rheumatol 16:691-705
49. Uribe AG, Romero-Diaz J, Apte M, Fernandez M, Burgos PI, Reveille JD, Sanchez-Guerrero J, Alarcon GS (2009) Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico. Rheumatology (Oxford) 48:1392-1397
50. Espinosa G, Berman H, Cervera R (2011) Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmun Rev 10:664-668
51. Newman KA, Akhtari M (2011) Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus. Autoimmun Rev 10:432-437
52. Pons-Estel GJ, Serrano R, Plasin MA, Espinosa G, Cervera R (2011) Epidemiology and management of refractory lupus nephritis. Autoimmun Rev 10:655-663
53. Bonaguri C, Melegari A, Ballabio A, Parmeggiani M, Russo A, Battistelli L, Aloe R, Trenti T, Lippi G (2011) Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results. Autoimmun Rev 11:1-5
54. Chimenti MS, Graceffa D, Perricone R (2011) Anti-TNFalpha discontinuation in rheumatoid and psoriatic arthritis: is it possible after disease remission? Autoimmun Rev 10:636-640
55. Andersson C, Larsson K, Vaziri-Sani F, Lynch K, Carlsson A, Cedervall E, Jonsson B, Neiderud J, Mansson M, Nilsson A et al (2011) The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity 44:394-405
56. Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, Lernmark A, Pociot F (2011) Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Autoimmunity 44:107-114
57. Conrad K, Roggenbuck D, Reinhold D, Sack U (2012) Autoantibody diagnostics in clinical practice. Autoimmun Rev 11:207-211
58. Fu SM, Deshmukh US, Gaskin F (2011) Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmun 37:104-112
59. Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM (2011) Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 36:65-75
60. Outschoorn IM, Talor MV, Hoffman WH, Rowley MJ, Mackay IR, Rose NR, Burek CL (2011) Autoantibody heritability in thyroiditis: IgG subclass contributions. Autoimmunity 44:195-200
61. Rodriguez-Reyna TS, Hinojosa-Azaola A, Martinez-Reyes C, Nunez-Alvarez CA, Torrico-Lavayen R, Garcia-Hernandez JL, Cabiedes-Contreras J (2011) Distinctive autoantibody profile in Mexican mestizo systemic sclerosis patients. Autoimmunity 44:576-584
62. Somers K, Geusens P, Elewaut D, De Keyser F, Rummens JL, Coenen M, Blom M, Stinissen P, Somers V (2011) Novel autoantibody markers for early and seronegative rheumatoid arthritis. J Autoimmun 36:33-46
63. Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stuve O (2011) The increasing incidence and prevalence of female multiple sclerosis -A critical analysis of potential environmental factors. Autoimmun Rev 10:495-502
64. Arnson Y, Amital H, Agmon-Levin N, Alon D, Sanchez-Castanon M, Lopez-Hoyos M, Matucci-Cerinic M, Szucs G, Shapira Y, Szekanecz Z et al (2011) Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev 10:490-494
65. Deshmukh US, Sim DL, Dai C, Kannapell CJ, Gaskin F, Rajagopalan G, David CS, Fu SM (2011) HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-Associated antigen SmD. J Autoimmun 37:254-262
66. Dillon SP, Kurien BT, Li S, Bruner GR, Kaufman KM, Harley JB, Gaffney PM, Wallace DJ, Weisman MH, Scofield RH (2012) Sex chromosome aneuploidies among men with systemic lupus erythematosus. J Autoimmun 38:J129-J134
67. Kapsogeorgou EK, Gourzi VC, Manoussakis MN, Moutsopoulos HM, Tzioufas AG (2011) Cellular microRNAs (miRNAs) and Sjogren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun 37:129-135
68. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, Bonnal RJ, Birolo RS, Moro M, Crosti MC, Gruarin P et al (2011) Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 12:796-803